122 related articles for article (PubMed ID: 34428509)
1. The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2.
Zhuang S; Xie J; Zhen J; Guo L; Hong Z; Li F; Xu D
Mol Cell Endocrinol; 2021 Nov; 537():111440. PubMed ID: 34428509
[TBL] [Abstract][Full Text] [Related]
2. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing
Ai J; Sun J; Zhou G; Zhu T; Jing L
Cell Cycle; 2020 Apr; 19(7):742-757. PubMed ID: 32089066
[TBL] [Abstract][Full Text] [Related]
4. ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.
Zou H; Chen H; Zhou Z; Wan Y; Liu Z
Cancer Lett; 2019 Dec; 467():19-28. PubMed ID: 31563563
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of eukaryotic translation initiation factor 5A2 in papillary thyroid cancer.
Zhang H; Zhang K; Ning L; Chen D; Hao F; Li P
Bioengineered; 2020 Dec; 11(1):1325-1333. PubMed ID: 33200656
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer.
Meng QB; Kang WM; Yu JC; Liu YQ; Ma ZQ; Zhou L; Cui QC; Zhou WX
PLoS One; 2015; 10(3):e0119229. PubMed ID: 25793713
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
[TBL] [Abstract][Full Text] [Related]
9. Sonic Hedgehog-GLI Family Zinc Finger 1 Signaling Pathway Promotes the Growth and Migration of Pancreatic Cancer Cells by Regulating the Transcription of Eukaryotic Translation Initiation Factor 5A2.
Xu X; Liu H; Zhang H; Dai W; Guo C; Xie C; Wei S; He S; Xu X
Pancreas; 2015 Nov; 44(8):1252-8. PubMed ID: 26465952
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6.
Wu X; Zhang X; Liu P; Wang Y
Pancreatology; 2023 Sep; 23(6):630-641. PubMed ID: 37460341
[TBL] [Abstract][Full Text] [Related]
15. [Effects of eukaryotic translation initiation factor 5A2 down-regulation by small interfering RNA on aggressiveness of MKN28 human].
Meng QB; Yu JC; Kang WM; Ma ZQ; Zhou L; Ye X; Cao ZJ; Tian SB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):482-7. PubMed ID: 25360644
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.
Zhu W; Cai MY; Tong ZT; Dong SS; Mai SJ; Liao YJ; Bian XW; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
Gut; 2012 Apr; 61(4):562-75. PubMed ID: 21813470
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
19. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer.
Tian SB; Yu JC; Liu YQ; Kang WM; Ma ZQ; Ye X; Yan C
World J Gastroenterol; 2015 Aug; 21(31):9337-47. PubMed ID: 26309359
[TBL] [Abstract][Full Text] [Related]
20. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
Zhang L; Zhang J; Li S; Zhang Y; Liu Y; Dong J; Zhao W; Yu B; Wang H; Liu J
RNA Biol; 2021 Apr; 18(4):547-562. PubMed ID: 32951513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]